0001209191-20-057368.txt : 20201106 0001209191-20-057368.hdr.sgml : 20201106 20201106191620 ACCESSION NUMBER: 0001209191-20-057368 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201105 FILED AS OF DATE: 20201106 DATE AS OF CHANGE: 20201106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLACIK CHARLES P CENTRAL INDEX KEY: 0001204660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 201295719 MAIL ADDRESS: STREET 1: 250 S. KRAEMER BLVD CITY: BREA STATE: CA ZIP: 92821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-05 0 0000353569 QUIDEL CORP /DE/ QDEL 0001204660 SLACIK CHARLES P 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 1 0 0 0 Common Stock 2020-11-05 4 M 0 4009 20.82 A 15224 D Common Stock 2020-11-05 4 S 0 4009 282.4614 D 11215 D Non-Qualified Stock Option 20.82 2020-11-05 4 M 0 4009 0.00 D 2016-05-05 2025-11-16 Common Stock 4009 0 D The amount of securities beneficially owned following this transaction include a reduction of shares due to the prior gifting of 137 shares by the reporting person to a bona fide charitable organization. The weighted average sale price for these transactions was $282.4614 per share, with a range of $282.11 to $282.60. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Robert J. Bujarski, attorney-in-fact for Charles P. Slacik 2020-11-06